93 related articles for article (PubMed ID: 3070031)
1. Treatment of hypertension with captopril: preservation of regional blood flow and reduced platelet aggregation.
James IM; Dickenson EJ; Burgoyne W; Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
J Hum Hypertens; 1988 Jun; 2(1):21-5. PubMed ID: 3070031
[TBL] [Abstract][Full Text] [Related]
2. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
[TBL] [Abstract][Full Text] [Related]
3. [Effect of captopril on platelet cytosolic [Ca2+]i and plasma TXA2/PGI2 in renovascular hypertensive rats].
Wei XR; Hu L; Du J
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):89-91. PubMed ID: 10375769
[TBL] [Abstract][Full Text] [Related]
4. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension.
Labiós M; Martínez M; Gabriel F; Guiral V; Aznar J
Thromb Res; 2006; 118(4):447-53. PubMed ID: 16242179
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
6. Free intracellular calcium in essential hypertension. Effects of nifedipine and captopril.
Lenz T; Haller H; Lüdersdorf M; Kribben A; Thiede M; Distler A; Philipp T
J Hypertens Suppl; 1985 Dec; 3(3):S13-5. PubMed ID: 2856689
[TBL] [Abstract][Full Text] [Related]
7. Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
Touyz RM; Schiffrin EL
J Hypertens; 1994 Nov; 12(11):1255-63. PubMed ID: 7868873
[TBL] [Abstract][Full Text] [Related]
8. [The effect of captopril on cerebral blood flow in hypertensive rats before and after cerebral ischemia].
Adzhienko LM
Eksp Klin Farmakol; 1999; 62(5):18-20. PubMed ID: 10572745
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
Ferrara LA; Rubba P; Iannuzzi A; Fasano ML
Int J Clin Pharmacol Res; 1984; 4(5):389-93. PubMed ID: 6394516
[TBL] [Abstract][Full Text] [Related]
10. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
[TBL] [Abstract][Full Text] [Related]
12. [Effects of captopril on the cerebral blood flow in the hypertensive aged subjects].
Larrue V; Dupui P; Pavy-Le Traon A; Allavoine T; Géraud G; Bès A
Arch Mal Coeur Vaiss; 1994 Aug; 87(8):997-1000. PubMed ID: 7755480
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy.
Manninen A
Pharmacol Toxicol; 1996 Jun; 78(6):387-91. PubMed ID: 8829198
[TBL] [Abstract][Full Text] [Related]
14. Dual effect of nitrate therapy for cyclosporine-induced hypertension on vascular and platelet morphofunctional markers; an animal model.
Reis F; Teixeira de Lemos E; Almeida L; Parada B; Garrido AP; Rocha-Pereira P; Santos-Silva A; Santos-Dias J; Dinis A; Figueiredo A; Costa-Almeida C; Mota A; Teixeira F
Transplant Proc; 2007 Oct; 39(8):2501-6. PubMed ID: 17954158
[TBL] [Abstract][Full Text] [Related]
15. Amlodipine in hypertension: its effects on platelet aggregation and dynamic exercise.
Hernández R; Carvajal AR; Armas-de Hernande MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragan O; Machado-de Alvarado I
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S25-7. PubMed ID: 16296703
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of oxidative-stress-induced platelet aggregation by androgen at physiological levels via its receptor is associated with the reduction of thromboxane A2 release from platelets.
Li S; Li X; Li J; Deng X; Li Y
Steroids; 2007 Nov; 72(13):875-80. PubMed ID: 17825336
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of low dose captopril once daily in diuretic resistant hypertension.
Baumgart P; Tenschert W; Vetter H
Postgrad Med J; 1986; 62 Suppl 1():127-30. PubMed ID: 3534846
[TBL] [Abstract][Full Text] [Related]
18. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
[TBL] [Abstract][Full Text] [Related]
19. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
Viisoreanu D; Gear A
Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats.
Li D; Peng J; Xin HY; Luo D; Zhang YS; Zhou Z; Jiang DJ; Deng HW; Li YJ
Peptides; 2008 Oct; 29(10):1781-8. PubMed ID: 18625276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
